Seminar - Online
Classical clinical trials and conclusions drawn from them are seen as not always useful aid for health care decision-making. The real-world data should provide the missing piece of information. Recently, there has been a growing need for Real-world evidence in the pharmaceutical HEOR world. Classical clinical trials and conclusions drawn from them are seen as not always useful aid for health care decision-making. The real-world data should provide the missing piece of information. More than a decade-long RWD study of AstraZeneca is now showing the first results – the comparative study helped to reduce the annual rate of moderate to severe exacerbations by 26%. Analyzing real-world data for health economics evaluations is still a young discipline and is still facing various organizational and educational challenges. How to improve the stakeholder dialog? Is your process in using RWD in coverage and reimbursement decision making successful enough? Join our webinar and learn!
Organization: Kakushin Group (www.kakushinwebinars.com)
For more information, please visit:
11 September, 2014 - 11 September, 2014
Bratislava Exhibition Ground, Bratislava, Slovakia
Online
Contact: Andrea Weber (andrea.weber@pharmafe.com)
Phone: +421257272174
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
